Greater Boston
Strategic communications leader with nearly a decade of experience in media relations, science communications, and reputation management across hospitals and life science companies. Proven track record of amplifying biomedical discoveries through top-tier press coverage (Wall Street Journal, Financial Times, STAT, Endpoints, FierceBiotech) and joint publication releases (The Lancet, New England Journal of Medicine). I am a trusted spokesperson and advisor to executives, faculty, and researchers—skilled in media training, Q&A preparation, issues response, and cross-institutional collaboration with universities, hospitals, advocacy groups, and industry. Calm under pressure, strategic in crisis, and dedicated to advancing science in service to humanity.
• Directed integrated communications for global biotech and health-technology clients, securing national coverage in The Wall Street Journal, The New York Times, Today Show, STAT, Endpoints, NEJM, and JAMA. • Created training programs and internal guidance on narrative consistency, data structure, and trust-building in AI-driven search and user-focused website experiences. • Allocated agency and vendor resources to advance client visibility and trust during product announcements, data presentations, and leadership transitions. • Developed performance-tracking KPIs to monitor sentiment, keyword adoption, and engagement metrics—translating insights into actionable media strategies. • Led cross-functional teams and media advisors to manage issues response, executive coaching, and content delivery across global markets. • Directed communications and provided strategic counsel to senior executives during product, policy, and organizational changes—ensuring consistent messaging across stakeholder groups. • Established and led Generative Engine Optimization (GEO) solutions to position clients for visibility in emergingsearch and generative discovery platforms. • Created standardized briefing documents, Q&A prep templates, and message frameworks adopted across agency and client teams. • Mentored account executives and interns, developing structured learning paths and growth plans aligned with organizational goals.
Coach, Boston University Figure Skating Team • Lead Ice Dance coach of 5-time Intercollegiate National Champion Figure Skating Team, BUFSC. • Responsible for facilitating mentorship, coaching, and athletic training of 40-50 athletes annually. • Developed and directed various fundraising, philanthropy, and development efforts under supervision of the Annual Giving Department, Boston University Capital Campaign, and Department of Physical Education Recreation and Dance. Highlights include participation in the kick-off (2012) and conclusion (2019) of Boston University's $1.85 Billion Campaign.
Graduate Assistant, Children’ s Programming and Ice Skating June 2019 - Present • Conduct communications research and develop marketing strategies for use in business development and client retention programs using multimodal marketing and customer tracking platforms to exceed ROI goals. • Design, manage, and evaluate marketing assets for a variety of program areas through web design, branding, social media, email marketing, satisfaction and quality surveys, slide decks, and presentation planning. • Develop curriculum, train, and manage undergraduate staff working in wellness and fitness programs/camps.
Associate Director, Global Corporate Communications (Global Hemophilia) August 2022 – December 2023 • Directed global communications for the hemophilia franchise, including the launch of ALTUVIIIO, translating complex science for novel mechanisms of action into newsworthy stories that generate momentum and highlight science. • Partnered with cross-functional teams to design targeted medical education initiatives that highlighted the distinct roles of the intrinsic vs. common pathways in clotting biology, advancing provider knowledge critical to therapeutic decision-making. • Led partnerships with major stakeholders including World Federation of Hemophilia, Harris Poll, BBC Storyworks, American Society of Hematology, and International Society on Thrombosis and Haemostasis.
Manager, Corporate Communications (Global Rare Blood Disorders) June 2021 – August 2022 • Collaborated closely with Medical, Health Economics and Outcomes Research, Market Access, and Regulatory Affairs to ensure compelling coverage around clinical data. • Executed cross-functional market-shaping initiatives, including patient storytelling, global campaigns, and investor-facing events. • Developed, edited, and published press releases, internal/external memos, media briefings, Q&A, and leadership town hall decks. • Created and executed omnichannel corporate communications across social, web, and third-party channels; monitored performance metrics to inform strategy.
New England Hearing Alliance 501(c)(3): Chestnut Hill, MA April 2017 - December 2019 President, Founding Board Member • Pioneered first non-profit business model for hearing aid distribution within private medical practices in MA using disruptive innovation strategies within strict regulatory and consumer protection guidelines. • Directed market research programs to develop deep understanding of patient needs, medical device experience, limiting factors, and health outcome goals. Resulting consumer profiles were used to identify appropriate business partnerships and to leverage strategic bargaining power in purchasing negotiations. • Identified and developed both retail and need-based solutions (hearing aids/audiology) for over 60 at-risk patients during the infancy of the business, proving viability for future expansion of non-profit care model. • Demonstrated excellent leadership across all assets: owning budgetary, regulatory, and purchasing decisions. • Acted as key opinion leader (KOL) in addressing hearing health business opportunities for other ENT otolaryngology and audiology clinics looking to expand in-house medical device services in New England. • Successfully facilitated business and patient care transition, including asset redistribution, after business transfer to new operating partner upon my departure.